CDB25:0003910 LRFN5 — PTPRD

Experimentally validated in Human, Mouse; Orthology-inferred in Human, Rat, Frog, Zebrafish, Chicken, Macaque, Pig, Dog, Cow, Chimp, Horse, Marmoset, Sheep, Mouse

Title

Journal:; Year Published:

Abstract

SALM5 trans-synaptically interacts with LAR-RPTPs in a splicing-dependent manner to regulate synapse development.

Scientific reports, 2016; PubMed, Homo sapiens LRFN5 — Homo sapiens PTPRD
ABSTRACT: Synaptogenic adhesion molecules play critical roles in synapse formation. SALM5/Lrfn5, a SALM/Lrfn family adhesion molecule implicated in autism spectrum disorders (ASDs) and schizophrenia, induces presynaptic differentiation in contacting axons, but its presynaptic ligand remains unknown. We found that SALM5 interacts with the Ig domains of LAR family receptor protein tyrosine phosphatases (LAR-RPTPs; LAR, PTPδ, and PTPσ). These interactions are strongly inhibited by the splice insert B in the Ig domain region of LAR-RPTPs, and mediate SALM5-dependent presynaptic differentiation in contacting axons. In addition, SALM5 regulates AMPA receptor-mediated synaptic transmission through mechanisms involving the interaction of postsynaptic SALM5 with presynaptic LAR-RPTPs. These results suggest that postsynaptic SALM5 promotes synapse development by trans-synaptically interacting with presynaptic LAR-RPTPs and is important for the regulation of excitatory synaptic strength.
Basic Information on LRFN5
Ligand Name: leucine rich repeat and fibronectin type III domain containing 5
Other Symbols: C14orf146, FIGLER8, SALM5
Ligand Location: cell membrane based on perplexity
Interactions with other Receptors for LRFN5
Basic Information on PTPRD
Receptor Name: protein tyrosine phosphatase receptor type D
Other Symbols: PTPD, HPTP
Receptor Location: cell membrane based on perplexity